Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency
Journal of Clinical Immunology · Published 2024-11-01 · Journal article · DOI 10.1007/s10875-024-01780-z · Cited by 5 (Crossref)
Authors (9)
Wenjing Ying, Xin Long, Travis Vandergriff, Hemanth Karnati, Meghan Heberton, Mingyi Chen, Xiaochuan Wang, Christian Wysocki, Xiao-Fei Kong
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Volume
- 44
- Issue
- 8
- Year
- 2024
Citation
Ying, W., Long, X., Vandergriff, T., et al. (2024). Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-024-01780-z
Related articles
- γδ T Cells as a Platform for Immunotherapy: From Biological Principles to Clinical Translation · Immunological Investigations · 2026 · Cites or is cited by this article
- Genetic Diagnosis and Identification of a Novel De Novo RELA Variant in Familial Behçet-like Autoinflammatory Syndrome Type 3: A Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy · Journal of Clinical Immunology · 2026 · Same journal
- Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation · Journal of Clinical Immunology · 2026 · Same journal
- Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Humoral Immune Abnormalities in Transient Childhood Neutropenia: Insights From a 10-year Cohort Study in a Tertiary Center · Journal of Clinical Immunology · 2026 · Same journal
- Phenotypic Heterogeneity in CD40 Ligand Deficiency: Long-term Follow-up of a Patient with the c.156G > A Splice Variant · Journal of Clinical Immunology · 2026 · Same journal
- First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults · Journal of Clinical Immunology · 2026 · Same journal
- Antigen Microarray Reveals Broad and Subclinical Autoimmunity in Patients with Inborn Errors of Immunity · Journal of Clinical Immunology · 2026 · Same journal
- Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome · Journal of Clinical Immunology · 2026 · Same journal
Metrics
- Citations (Crossref)
- 5